Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 27, 2013
View Archived Issues
Scientists at Tangrun Pharmaceuticals synthesize new HCV protease inhibitors
Read More
Takara Bio files gene therapy IND with Korean agency
Read More
EMA recommends approval of Sanofi Pasteur pediatric vaccine
Read More
Ignyta enters collaboration with Leiden University Medical Center
Read More
Nanologica to develop nanotechnology drugs with Russian biotech company
Read More
Antisense Pharma revises development strategy for anticancer candidate
Read More
CBK-201352 shows potent trypanotoxic activity in vitro and in vivo
Read More
Arrhythmogenic right ventricular dysplasia model established in vitro
Read More
Merck KGaA patents new LPA2 receptor antagonists
Read More
Novel agents for tuberculosis and cancer disclosed by CSIR
Read More
Researchers at the University of California synthesize novel GABA(A) receptor modulators
Read More
Japanese group discloses new ERRalpha inverse agonists
Read More
Novel first-in-class therapies hold promise in phase I for acute allergic reactions
Read More
Royalty Pharma proposes to acquire Elan
Read More
Mitsubishi Tanabe Pharma seeks additional indication for Tenelia in Japan
Read More
Shionogi applies for approval of Predonine in Japan
Read More
Isis Pharmaceuticals begins phase II study of ISIS-CRPRx in atrial fibrillation
Read More
Psyadon enrolls first patients in phase III study of ecopipam in Lesch-Nyhan disease
Read More
Inviragen develops dual-purpose recombinant MVA biodefense vaccine
Read More
Lytix Biopharma begins new phase II trial of LTX-109 for impetigo
Read More
Amarin files sNDA for Vascepa
Read More
United Therapeutics plans first clinical study of Pluristem's PLX-PAD cells in PAH
Read More
FDA approves Osphena for the treatment of dyspareunia
Read More
Arbovax creates tetravalent dengue virus vaccine
Read More
Likely delay to FDA review of Zohydro ER
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe